TPG has spent the past week climbing 3.4% to $44.64 — but the more interesting story is happening in the lending market, where short sellers have sharply rebuilt their positions even as the price edges higher.
Short interest jumped 23.6% over the past week, reaching 7.1% of the free float. The move was abrupt: from June 8 to June 9, short shares barely budged from their prior-week level near 8.4 million. Then, starting June 9, borrowing accelerated sharply — adding roughly two million shares in five trading sessions to reach 10.4 million by June 16. That's a meaningful repositioning in a compressed window, and it coincides almost exactly with the stock's recovery off its April lows. The borrow market, however, is not under stress. Cost to borrow has actually eased nearly 18% over the week to 0.42% — essentially free — and availability remains extremely loose at 1,519%, meaning there are far more shares available to lend than are currently borrowed. New shorts face no meaningful friction entering positions. The options market adds a layer of caution: the put/call ratio runs at 4.76, modestly above its 20-day average of 4.40 and about 1.25 standard deviations elevated. That reading is well off the 52-week high of 6.63, so it signals mild defensiveness rather than panic, but the direction of travel — PCR drifted from roughly 3.1 in mid-May to nearly 4.8 now — is a steady drift toward protective positioning.
The Street is broadly constructive but has spent much of the year revising lower. The current mean price target of $56 implies about 25% upside from here, and several large firms have kept positive ratings intact — UBS maintained a Buy and raised its target to $59 in early May, while Barclays kept its Overweight and moved to $58. But context matters: Goldman Sachs cut its target from $80 to $55 in April, and UBS itself slashed from $83 to $60 in February before the subsequent raise. The net message is a Street that believes in the name at current levels but sharply reduced what it believes the stock is worth over the prior six months. TD Cowen moved its Hold target modestly lower to $45 in mid-May, essentially flagging that the near-term upside case is limited from where the stock traded then. Valuation has drifted higher with the price recovery — the P/E multiple has added about 0.85 turns over the past week and 0.81 turns over the past month to sit near 14.1x. Price-to-book has similarly moved, adding 0.47 turns over the past month to 6.38x. The forward EPS year-over-year growth factor ranks in the 87th percentile, which is the standout strength in TPG's factor profile — the dividend score is also high at 93rd percentile, though the dividend history in the data is stale and should not be read as a current yield signal. The short score of 47.6 has drifted higher from 42.9 two weeks ago but remains in neutral territory, placing TPG in the 25th percentile of its peer universe on short positioning — not a crowded short by any measure.
Institutional ownership tells a supportive story at the top of the register. Temasek holds 6.2% and added 1.2 million shares in the most recent reported period; Wellington added 2.2 million shares and Millennium added 2.5 million. Darlington Partners made the most aggressive move, nearly quintupling its stake to nine million shares — a 4.1 million share addition that puts it at 5.6% of the company. Against that backdrop, insider activity has been one-directional: the CEO sold $27.5 million of stock in January, the CFO and COO each sold several million, and the founder sold $6.8 million. All of those sales occurred at $66 per share, well above the current price. The net 90-day insider position shows a small positive balance, but that's explained by an award grant to the CEO rather than open-market purchases. The selling cluster at $66 is now 33% above where the stock trades — a data point that frames the current price as a discount to where management was happy to exit. Peers moved broadly in line with TPG on the week — KKR added 3.3%, ARES added 3.3%, and CG rose 3.7%, suggesting the sector tailwind rather than any TPG-specific catalyst drove this week's recovery. STEP was the outlier, surging 12.2%.
The next earnings event is scheduled for August 6. The recent history is modest in magnitude: the two most recent prints produced next-day moves of -0.6% and -0.9% respectively, with a one-day gain of 3.2% in the print before those. Five-day reactions have been similarly contained. The setup heading into that date — shorts rebuilding near 7% of float, options drifting mildly more defensive, and a recovery in price from April lows that has not yet reclosed the gap to analyst targets — makes the August print one where the pace of AUM growth and any guidance on deployment will determine whether the recent re-rating has legs.
See the live data behind this article on ORTEX.
Open TPG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
